DBV Technologies (DBVT) EBT Margin Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 48,476.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 441.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -408.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,297.00 |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -432,952.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -432,952.00 |
| Dec 31, 2025 | -990,283.00 |
| Sep 30, 2025 | -36,202.00 |
| Jun 30, 2025 | -134,357.00 |
| Mar 31, 2025 | -273,475.00 |
| Dec 31, 2024 | -403,703.00 |
| Sep 30, 2024 | -102,319.00 |
| Jun 30, 2024 | -76,312.00 |
| Mar 31, 2024 | -93,978.00 |
| Dec 31, 2023 | -338,560.00 |
| Sep 30, 2023 | 3,874.00 |
| Jun 30, 2023 | 27,618.00 |
| Mar 31, 2023 | -7,035.00 |
| Sep 30, 2022 | 35,724.00 |
| Dec 31, 2021 | -95,862.00 |
| Sep 30, 2021 | -35,827.00 |
| Dec 31, 2018 | 96,367.00 |